Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1.
Publication
, Journal Article
Armstrong, PW; Collen, D
Published in: Circulation
June 12, 2001
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
June 12, 2001
Volume
103
Issue
23
Start / End Page
2862 / 2866
Location
United States
Related Subject Headings
- Treatment Outcome
- Recombinant Proteins
- Myocardial Reperfusion
- Myocardial Infarction
- Metabolic Clearance Rate
- Humans
- Hemorrhage
- Fibrinolytic Agents
- Fibrin
- Dose-Response Relationship, Drug
Citation
APA
Chicago
ICMJE
MLA
NLM
Armstrong, P. W., & Collen, D. (2001). Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1. Circulation, 103(23), 2862–2866. https://doi.org/10.1161/01.cir.103.23.2862
Armstrong, P. W., and D. Collen. “Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1.” Circulation 103, no. 23 (June 12, 2001): 2862–66. https://doi.org/10.1161/01.cir.103.23.2862.
Armstrong PW, Collen D. Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1. Circulation. 2001 Jun 12;103(23):2862–6.
Armstrong, P. W., and D. Collen. “Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1.” Circulation, vol. 103, no. 23, June 2001, pp. 2862–66. Pubmed, doi:10.1161/01.cir.103.23.2862.
Armstrong PW, Collen D. Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1. Circulation. 2001 Jun 12;103(23):2862–2866.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
June 12, 2001
Volume
103
Issue
23
Start / End Page
2862 / 2866
Location
United States
Related Subject Headings
- Treatment Outcome
- Recombinant Proteins
- Myocardial Reperfusion
- Myocardial Infarction
- Metabolic Clearance Rate
- Humans
- Hemorrhage
- Fibrinolytic Agents
- Fibrin
- Dose-Response Relationship, Drug